Indeed, CD4 + CD28- T lymphocytes from RA patients exhibit higher concentrations of the receptor activator of nuclear factor kappa-Β ligand (RANKL) than CD28+ cells [55]. This evidence concerns the gene CD28 and rheumatoid arthritis.